Lataa...
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor
The NLRP3 inflammasome plays a crucial role in innate immune-mediated inflammation and contributes to the pathogenesis of multiple autoinflammatory, metabolic and neurodegenerative diseases, but medications targeting the NLRP3 inflammasome are not available for clinical use. RRx-001 is a well-tolera...
Tallennettuna:
| Julkaisussa: | Cell Mol Immunol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8166941/ https://ncbi.nlm.nih.gov/pubmed/33972740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-021-00683-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|